Royal Philips swings to wider-than-forecast net loss of $1.31 billion

The Dutch health-technology company said that it saw prolonged operational and supply challenges, a worsening macro-economic environment, as well as continued uncertainty related to Covid-19 measures in China.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.